I don't think anyone is arguing with differences of opinion but it more around analysis or reasoning of sell recommendations is in question. As it was a lazy analysis with no real analysis or research is in question here
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19, page-216
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.19 |
Change
0.015(1.28%) |
Mkt cap ! $1.347B | |||
| Open | High | Low | Value | Volume |
| $1.17 | $1.22 | $1.17 | $3.296M | 2.780M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 26 | 23262 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.19 | 24974 | 17 |
View Market Depth
| Last trade - 13.35pm 01/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |